StockData
LMMYOTCServices-Educational ServicesFiscal year ends May 31

Exousia Bio, Inc.

Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Jun 16, 2026
$0.01−0.00 (-18.29%)

Close on Oct 19, 2026

Market cap
$175.47K
P/E (TTM)
–
Dividend yield
–

Exousia Bio, Inc. revenue by segment

No segment breakdown reported

Exousia Bio does not break out revenue by segment, region or product in the tagged data of its filings for this period type.